Patients with amyotrophic lateral sclerosis (ALS) can be treated with a drug used against Parkinson’s. In addition, this drug managed to delay the progression of the pathology to an average of 27.9 weeks, precisely in a small clinical trial.
However, according to what was published in El Periódico, we must wait to confirm the effectiveness. more tests are needed.
“ALS is a deadly motor neuron disease that causes people to gradually lose control of their muscles. There is no cure and current treatments focus on reducing symptoms and providing supportive care.”
Safe drug for amyotrophic lateral sclerosis
“The drug ropinirole in a clinical trial with patients with sporadic, ie, nonfamilial, ALS” has been approved, according to a Japanese study published in Cell Stem Cell.
“This trial has shown that the drug is safe in ALS patients and that it potentially has some therapeutic effect.but further studies are needed to confirm its efficacy, so a phase 3 trial is planned for the near future,” said Hideyuki Okano, a member of Tokyo Keio University, lead author.